Related Experiment Video
Updated: Jun 10, 2025

Author Spotlight: Unveiling Mitochondrial Function and Cellular Metabolic Adaptation in Metabolic Diseases
Published on: October 4, 2024
Metabolic pathways for removing reactive aldehydes are diminished in the skeletal muscle during heart failure
Mamata Chaudhari1,2, Igor Zelko1,2, Pawel Lorkiewicz1,2
1Center for Cardiometabolic Science, Louisville, KY, USA.
Abstract:
Muscle wasting is a serious complication in heart failure patients. Oxidative stress and inflammation are implicated in the pathogenesis of muscle wasting. Oxidative stress leads to the formation of toxic lipid peroxidation products, such as 4-hydroxy-2-nonenal (HNE), which covalently bind with proteins and DNA and activate atrophic pathways. Whether the formation of lipid peroxidation products and metabolic pathways that remove these toxic products are affected during heart failure-associated skeletal muscle wasting has never been studied. Male C57BL/6J mice were subjected to sham and transverse aortic constriction (TAC) surgeries for 4, 8 or 14 weeks. Different skeletal muscle beds were weighed, and the total cross-sectional area of the gastrocnemius muscle was measured via immunohistochemistry. Muscle function and muscle stiffness were measured by a grip strength meter and atomic force microscope, respectively. Atrophic and inflammatory marker levels were measured via qRT‒PCR. The levels of acrolein and HNE-protein adducts, aldehyde-removing enzymes, the histidyl dipeptide-synthesizing enzyme carnosine synthase (CARNS), and amino acid transporters in the gastrocnemius muscle were measured via Western blotting and qRT‒PCR. Histidyl dipeptides and histidyl dipeptide aldehyde conjugates in the Gastrocnemius and soleus muscles were analyzed by LC/MS-MS. Body weight, gastrocnemius muscle and soleus muscle weights and the total cross-sectional area of the gastrocnemius muscle were decreased after 14 weeks of TAC. Heart weight, cardiac function, grip strength and muscle stiffness were decreased in the TAC-operated mice. Expression of the atrophic and inflammatory markers Atrogin1 and TNF-α, respectively, was increased ~ 1.5-2fold in the gastrocnemius muscle after 14 weeks of TAC (p < 0.05 and p = 0.004 vs sham). The formation of HNE and acrolein protein adducts was increased, and the expression of the aldehyde-removing enzyme aldehyde dehydrogenase (ALDH2) was decreased in the gastrocnemius muscle of TAC mice. Carnosine (sham: 5.76 ± 1.3 vs TAC: 4.72 ± 0.7 nmol/mg tissue, p = 0.04) and total histidyl dipeptide levels (carnosine and anserine; sham: 11.97 ± 1.5 vs TAC: 10.13 ± 1.4 nmol/mg tissue, p < 0.05) were decreased in the gastrocnemius muscle of TAC mice. Depletion of histidyl dipeptides diminished the aldehyde removal capacity of the atrophic gastrocnemius muscle. Furthermore, CARNS and TAUT protein expression were decreased in the atrophic gastrocnemius muscle. Our data reveals that reduced expression of ALDH2 and depletion of histidyl dipeptides in the gastrocnemius muscle during heart failure leads to the accumulation of toxic aldehydes and might contribute to muscle wasting.
Insights
Heart failure causes muscle wasting by increasing toxic aldehydes and decreasing protective compounds like carnosine. This study shows reduced aldehyde removal contributes to muscle loss in heart failure.
Area of Science:
- Biochemistry
- Physiology
- Pathology
Background:
- Muscle wasting is a critical complication in heart failure patients, linked to oxidative stress and inflammation.
- Oxidative stress generates toxic lipid peroxidation products, such as 4-hydroxy-2-nonenal (HNE), which damage proteins and DNA, activating muscle atrophy pathways.
- The impact of heart failure on the formation and removal of these toxic products in skeletal muscle has not been previously investigated.
Purpose of the Study:
- To investigate the role of lipid peroxidation product formation and removal pathways in skeletal muscle wasting associated with heart failure.
- To examine the expression of aldehyde-removing enzymes, histidyl dipeptides, and related synthesis/transport proteins in the context of heart failure-induced muscle atrophy.
Main Methods:
- Male C57BL/6J mice underwent sham or transverse aortic constriction (TAC) surgery, with analyses at 4, 8, and 14 weeks.
- Measurements included muscle weight, cross-sectional area, grip strength, muscle stiffness, and expression of atrophic/inflammatory markers (Atrogin1, TNF-α).
- Levels of acrolein and HNE-protein adducts, aldehyde-metabolizing enzymes (ALDH2), carnosine synthase (CARNS), amino acid transporters, and histidyl dipeptides were quantified using Western blotting, qRT-PCR, and LC/MS-MS.
Main Results:
- TAC mice exhibited decreased body weight, skeletal muscle mass (gastrocnemius, soleus), grip strength, and cardiac function after 14 weeks.
- Increased formation of HNE and acrolein protein adducts and decreased expression of aldehyde dehydrogenase (ALDH2) were observed in the gastrocnemius muscle of TAC mice.
- Levels of carnosine and total histidyl dipeptides were reduced in TAC mice, diminishing aldehyde removal capacity, alongside decreased CARNS and TAUT protein expression.
Conclusions:
- Reduced expression of ALDH2 and depletion of histidyl dipeptides in skeletal muscle contribute to the accumulation of toxic aldehydes during heart failure.
- These molecular changes likely play a significant role in the pathogenesis of heart failure-associated skeletal muscle wasting.
- Targeting aldehyde detoxification pathways and histidyl dipeptide levels may offer therapeutic strategies for mitigating muscle loss in heart failure.
More Related Videos
12:24Methods for the Determination of Rates of Glucose and Fatty Acid Oxidation in the Isolated Working Rat Heart
Published on: September 28, 2016
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Pathophysiology of Heart Failure
Muscle Recovery and Fatigue
Other Glycolytic Pathways
Heart Failure II: Pathophysiology
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Metabolic States of the Body: Fasting and Starvation